Table 4.

The antimicrobial activity of the newly synthesized compounds represented in MIC (µg/mL) toward Streptococcus mutant, Pseudomonas aeruginosa, and Candida albicans.

Compound	Streptococcus mutant	Pseudomonas aeruginosa	Candida albicans
Ampicillin	13.5 ± 0.234	–	–
Ciprofloxacin	–	18.7 ± 0.475	–
Clotrimazole	–	–	14.5 ± 1.25
2	49.71 ± 0.5849	40.13 ± 2.109	52.77 ± 0.7862
3	11.12 ± 0.4232	18.29 ± 2.114	40.74 ± 0.5511
4	34.41 ± 0.2374	60.76 ± 2.218	48.92 ± 1.054
5	43.52 ± 0.359	56.51 ± 2.191	59.02 ± 1.285
6	39.58 ± 0.3478	58.47 ± 2.267	57.3 ± 1.32
7	22.42 ± 0.3173	43.86 ± 2.042	58.18 ± 1.207
8	15.77 ± 0.2052	53.05 ± 2.183	56.17 ± 1.235
9	48.77 ± 0.2457	61.51 ± 1.832	46.61 ± 1.195